On Demand March 5, 2008
Cardiometabolic Syndrome: Understanding Risk and Treatment
Broadcast Date: March 5, 2008
The growing prevalence of the cardiometabolic syndrome (CMS) has been related to obesity, which has increased among many age groups. It is currently accepted that CMS predicts cardiovascular mortality and/or the development of type 2 diabetes mellitus. CMS is further complicated by modifications in body composition and fat redistribution and is often associated with altered insulin sensitivity. The primary goal of clinical management of the metabolic syndrome is to reduce the risk for type 2 diabetes and cardiovascular disease.
For more information, view the conference flyer.
Physicians, nurse practitioners, nurses, physician assistants, pharmacists, dietitians and social workers.
None for this program
Contact for Technical Assistance
334-206-5618 or email ALPHTN
Page last updated: April 5, 2017